Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

Cancer immunotherapy has made impressive advances in improving the outcome of patients affected by malignant diseases. Nonetheless, some limitations still need to be tackled to more efficiently and safely treat patients, in particular for those affected by solid tumors. One of the limitations is rel...

Full description

Bibliographic Details
Main Authors: Marsha Pellegrino, Valerio Secli, Silvia D’Amico, Lucia Lisa Petrilli, Matteo Caforio, Valentina Folgiero, Nicola Tumino, Paola Vacca, Maria Vinci, Doriana Fruci, Emmanuel de Billy
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
immuno-oncotherapy
tumor microenvironment
IGF1R
cancer immunity
immunomodulation
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1356321/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1356321/full

Similar Items